Shared on 01 May 25
Fair value Increased 1.26%New Facilities And Diversified Segments Will Amplify Industry Presence
Shared on 23 Apr 25
Diversification Into Ice Cream, OTC Pharmaceuticals, And Footwear Will Transform Business Profile Over The Next Few Years
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Diversification Into Ice Cream, OTC Pharmaceuticals, And Footwear Will Transform Business Profile Over The Next Few Years
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Diversification Into Ice Cream, OTC Pharmaceuticals, And Footwear Will Transform Business Profile Over The Next Few Years
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 6.25%Diversification Into Ice Cream, OTC Pharmaceuticals, And Footwear Will Transform Business Profile Over The Next Few Years
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Diversification Into Ice Cream, OTC Pharmaceuticals, And Footwear Will Transform Business Profile Over The Next Few Years
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Diversification Into Ice Cream, OTC Pharmaceuticals, And Footwear Will Transform Business Profile Over The Next Few Years
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Decreased 9.47%Diversification Into Ice Cream, OTC Pharmaceuticals, And Footwear Will Transform Business Profile Over The Next Few Years
AnalystConsensusTarget has decreased future PE multiple from 54.0x to 46.2x.